LIS1 Regulates Osteoclast Formation and Function through Its Interactions with Dynein/Dynactin and Plekhm1 by Ye, Shiqiao et al.
LIS1 Regulates Osteoclast Formation and Function
through Its Interactions with Dynein/Dynactin and
Plekhm1
Shiqiao Ye
1, Tristan W. Fowler
2, Nathan J. Pavlos
3, Pei Ying Ng
3, Kai Liang
4, Yunfeng Feng
5, Minghao
Zheng
3, Richard Kurten
2, Stavros C. Manolagas
1, Haibo Zhao
1*
1Center for Osteoporosis and Metabolic Bone Diseases, Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Arkansas for Medical
Sciences and the Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, United States of America, 2Department of Physiology and Biophysics, University of
Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America, 3Center for Orthopedic Research, School of Surgery, University of Western Australia, Perth,
Australia, 4Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America, 5Department of Internal Medicine,
Washington University School of Medicine, St. Louis, Missouri, United States of America
Abstract
Microtubule organization and lysosomal secretion are both critical for the activation and function of osteoclasts, highly
specialized polykaryons that are responsible for bone resorption and skeletal homeostasis. Here, we have identified a novel
interaction between microtubule regulator LIS1 and Plekhm1, a lysosome-associated protein implicated in osteoclast
secretion. Decreasing LIS1 expression by shRNA dramatically attenuated osteoclast formation and function, as shown by a
decreased number of mature osteoclasts differentiated from bone marrow macrophages, diminished resorption pits
formation, and reduced level of CTx-I, a bone resorption marker. The ablated osteoclast formation in LIS1-depleted
macrophages was associated with a significant decrease in macrophage proliferation, osteoclast survival and differentiation,
which were caused by reduced activation of ERK and AKT by M-CSF, prolonged RANKL-induced JNK activation and declined
expression of NFAT-c1, a master transcription factor of osteoclast differentiation. Consistent with its critical role in
microtubule organization and dynein function in other cell types, we found that LIS1 binds to and colocalizes with dynein in
osteoclasts. Loss of LIS1 led to disorganized microtubules and aberrant dynein function. More importantly, the depletion of
LIS1 in osteoclasts inhibited the secretion of Cathepsin K, a crucial lysosomal hydrolase for bone degradation, and reduced
the motility of osteoclast precursors. These results indicate that LIS1 is a previously unrecognized regulator of osteoclast
formation, microtubule organization, and lysosomal secretion by virtue of its ability to modulate dynein function and
Plekhm1.
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Introduction
Osteoclasts are terminally differentiated polykaryons that are
uniquely capable of digesting calcified bone matrix. They are
formed by fusion of mononuclear precursors of the monocyte/
macrophage lineage [1,2]. Receptor activator of nuclear factor
kappa B (NF-kB) ligand (RANKL) and macrophage colony-
stimulating factor (M-CSF) are the essential cytokines for
osteoclastogenesis[3]; and NFATc1 is the master transcription
factor responsible for osteoclast differentiation and function.
NFATc1 is induced by RANKL and co-activated by immuno-
globulin-like receptors and their associated adapter proteins [4,5].
As they mature, osteoclasts undergo dramatic reorganization of
their cytoskeleton. Filamentous actin (F-actin) is first organized
into podosomes, highly dynamic structures that mediate cell
adhesion and migration of osteoclasts. When osteoclasts are
cultured on glass or plastic, individual podosomes are clustered
and expand to the cell periphery to form a stable ‘‘podosome belt’’
[6,7]. When osteoclasts are cultured on bone, F-actin forms a ring-
like structure (actin-ring) at the sealing zone, a tight adhesion
structure where the osteoclast plasma membrane is juxtaposed to
bone [8]. The sealing zone surrounds a specialized plasma
membrane domain, the ruffled border, thus forming an isolated
resorptive microenvironment between the osteoclast and the
underlying bone matrix. The ruffled border is generated by the
fusion of secretory vesicles with the bone-apposing plasma
membrane. During this process, protons and lysosomal enzymes
(predominantly cathepsin K) are vectorially secreted into the
resorption lacuna to dissolve bone mineral and digest organic
matrix, respectively [9]. It has been recently shown that the
network of microtubules regulates podosome patterning in
osteoclasts and thus is essential for osteoclast spreading and the
sealing zone formation [10,11]. One of the mechanisms of
microtubule stabilization in osteoclasts is regulated by tubulin
acetylation. This process is controlled by a Rho-mDia2-HDAC6
pathway where activation of small GTPase Rho promotes the
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e27285deacetylation of tubulin through the activation of Rho down-
stream effector mDia2 and the histone deacetylase HDAC6. The
protein tyrosine kinase Pyk2 and Cbl family members of adaptor
proteins regulate actin-ring formation and bone resorption, at least
in part, through their modulation of Rho and HDAC6 activities
[12,13].
During the last few years, genetic studies of patients with
osteopetrosis as well as naturally occurring mutation or gene-
targeting in mice have elucidated important regulatory proteins
that control osteoclastic bone resorption [3,14]. Among these
proteins, carbonic anhydrase II, a3 subunit of vacuolar proton
pump, Clc-7 chloride channel, OSTM1 (b subunit of Clc-7) are
essential for handling proton generation and acidification of the
resorption lacuna. Cathepsin K is crucial for bone degradation.
More recently, mutations of the PLEKHM1 gene have been
identified as the cause of the osteopetrotic ia/ia (incisors absent) rat
as well as a subset of patients with intermediate osteopetrosis [15].
The ia/ia rat exhibits generalized osteopetrosis and delay in tooth
eruption that is inherited in an autosomal recessive manner [16].
Osteoclasts in ia/ia rats exhibit abnormal sealing zone formation
and an intrinsic defect in ruffled border formation with
accumulation of intracellular lysosomal enzymes [17], reflecting
dysfunctions in intracellular vesicular trafficking pathways. Recent
segregation analysis has localized the gene responsible for these
abnormalities to rat chromosome 10q32.1 [18]. Sequence analysis
of rat and human genomes has uncovered mutations in the
PLEKHM1 gene in ia/ia rats and in a family with an intermediate
form of osteopetrosis. Consistently, osteoclasts derived from
peripheral blood monocytes from these individuals have impaired
resorptive activity [15]. Plekhm1
R714C heterozygous mutation
impairs vesicular acidification and increases TRAP secretion in
osteoclasts [19]. Overexpression studies in HEK293 and osteo-
clast-like cells derived from the Raw 264.7 macrophages
demonstrated that Plekhm1 is co-localized with Rab7 at late
endosomes and lysosomes. Furthermore, a dominant negative
mutant of Rab7 disrupts the association of Plekhm1 with
lysosomes. Taken together, these findings suggest that Plekhm1
is a component of Rab7-regulated late endosomal trafficking in
osteoclasts [15] and possibly in other cells as well [20]. However,
the mechanism(s) by which Plekhm1 regulates this process remains
unknown.
Haploinsufficiency of LIS1 (official symbol PAFAH1b1, for
platelet-activating factor (PAF) acetylhydrolase isoform 1b subunit
1) causes lissencephaly, a severe human developmental brain
disorder manifested by a smooth cerebral surface and disorganized
cortical layers due to incomplete neuronal migration [21,22].
LIS1-null mice are embryonic lethal at the implantation stage and
heterozygous mice exhibit delayed neuronal migration and defects
in cortical development [23]. Biochemical and genetic studies have
revealed that LIS1, together with its binding proteins NDE1/
NDEL1, form an evolutionary conserved pathway that regulates
microtubule dynamics and the function of the retrograde
molecular motor, cytoplasmic dynein. Indeed LIS1 and NDE1/
NDEL1 are required in several dynein-mediated processes
including nuclear and centrosome positioning and movement in
migrating neuronal and non-neuronal cells; chromosome align-
ment and mitotic spindle orientation in proliferating cells;
intracellular vesicular transport; and neuronal growth cone
advance [24,25]. LIS1 also serves as the non-catalytic b subunit
of PAFAH 1b in complex with homo- or hetero-dimers of the
catalytic subunits a1 and a2 [22,26]. LIS1 may regulate the
activity or the localization of PAFAH 1b complex which
inactivates intracellular PAF by removing the acetyl group at the
sn-2 position of the glycerol backbone of PAF [27]. A previous
report has implicated PAF as an important autocrine factor for
osteoclast survival and function. PAF receptor deficient mice are
protected from osteoporosis following ovariectomy [28]. Given the
important role of both microtubules and PAF in osteoclast biology
we hypothesized that LIS1 may regulate bone homeostasis. The
skeletal phenotypes of lissencephaly patients and the LIS1
heterozygous knockout mice have not been defined so far.
In the present report we have identified that LIS1 interacts with
Plekhm1. LIS1 also forms complexes with dynein/dynactin in
osteoclasts. Decreasing LIS1 expression by shRNA results in an
aberrant M-CSF and RANKL signaling; altered microtubule
organization; the perinuclear accumulation of lysosomes around
the nucleus; and a decrease in osteoclast precursor proliferation,
survival, motility and cathepsin K secretion. Thus, loss of LIS1
expression dramatically attenuates the formation of multinucleated
osteoclasts and the bone resorption function of the mature cells by
interfering with microtubule/dynein and Plekhm1pathways.
Results
LIS1 and Plekhm1 interact in osteoclasts
Plekhm1 is a cytoplasmic protein containing a RUN (RPIP8/
UNC-14/NESCA) domain, two PH (Pleckstrin Homology)
domains and a lipid binding and responsive C1 (protein kinase
C conserved region 1) domain (Figure S1). We (Figure S2) and
others [15] have previously demonstrated that Plekhm1 is
associated with lysosomes in osteoclasts and regulates cathepsin
K secretion. However, the precise functions of Plekhm1 remain
unknown. To better understand how Plekhm1 might regulate
osteoclast activity we first sought to identify its potential binding
proteins. The GST fusion proteins of individual domains of mouse
Plekhm1 were used to pull-down associated proteins from mature
murine osteoclast lysates. As shown in Figure 1A, a ,50 kDa band
appeared specifically in GST-RUN domain pull-down but not in
that of GST, as visualized by Coomassie blue staining. Mass
spectrometry analysis of proteins in this band revealed that it
contained both Plekhm1 RUN domain and LIS1. When the pull-
downs from each Plekhm1 domain were probed by western blot
with anti-LIS1 antibody, LIS1 was associated with both the RUN
and PH1 domains of Plekhm1 (Figure 1B). The interaction
between LIS1 and Plekhm1 was further confirmed by co-
immunoprecipitation of endogenous LIS1 with HA tagged full
length Plekhm1, the N-terminal half of Plekhm1 which contains
the RUN domain and the C-terminal half of Plekhm1 which
contains the PH1, PH2 and C1 domains (Figure 1C, upper
panels). In contrast, endogenous dynein intermediate chain (DIC)
was not immunoprecipitated with HA-Plekhm1, indicating that
DIC did not interact with Plekhm1 directly (Figure 1C, middle
panels). To further map which part(s) of Plekhm1 interact with
LIS1, we retrovirally transduced a series of truncated fragments of
murine Plekhm1 into bone marrow macrophages (BMMs) which
were further cultured with M-CSF and RANKL for 5 days to
generate osteoclasts (Figure 1D). While immunoprecipitated
endogenous LIS1 was associated with the C-terminal half of
Plekhm1, deletion of the RUN and/or PH1 domains abolished
Plekhm1-LIS1 interaction (Figure 1D). Thus, the data from these
GST pull-down and reciprocal immunoprecipitation experiments
demonstrate that Plekhm1 binds to LIS1 through both RUN and
PH1 domains.
LIS1 is indispensible for osteoclast formation and
function
To elucidate the role of LIS1 in osteoclasts we next proceeded
to knock down its expression by lenti-virus mediated shRNA
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blotting using a monoclonal antibody specific to LIS1 (Figure 2A,
upper panel). Western blots for cathepsin K and DIC served as a
marker of osteoclast differentiation and loading control, respec-
tively (Figure 2A, middle and lower panels). LIS1 protein levels
were potently suppressed in the LIS1b shRNA (LIS1b-sh)
transduced BMMs, pre-osteoclasts and mature osteoclasts as
compared with those in control cells transduced with shRNA
targeting fire fly luciferase (LUC-sh). In contrast, LIS1a shRNA
(LIS1a-sh) expression resulted in only a modest reduction of LIS1
protein level. The osteoclast formation and cathepsin K expression
in LIS1a-sh expressing cells were indistinguishable from those of
control LUC-sh cells (Figure 2A and data not shown). We
thereafter used LIS1b-sh, designated now as LIS1-sh, to inhibit
LIS1 expression in osteoclasts in the following experiments.
Decreased LIS1 expression by LIS1-sh dramatically attenuated
the formation of multinucleated osteoclasts as revealed by tartrate-
resistant acid phosphatase (TRAP) staining and quantification
(Figure 2B and 2C), and a significant decrease in cathepsin K
expression in LIS1b-sh expressing osteoclasts (Figure 2A, middle
panel). When cultured on bone slices, the total area of resorption
pits was significantly reduced in LIS1-sh expressing osteoclasts as
compared with control cells (Figure 2D and 2E). More
importantly, the concentration of CTx-I, fragment of collagen
released from bone into the medium, was 10 times lower in LIS1-
sh knockdown osteoclasts (Figure 2F). These effects were not due
to an off-target phenomenon caused by overexpression of shRNAs,
because expression of an independent LIS1 shRNA, which targets
Figure 1. Plekhm1 is a novel LIS1-interacting protein in osteoclasts. (A and B) Endogenous LIS1 binds to RUN and PH1 domains of Plekhm1.
GST and GST fusion proteins of individual domain of mouse Plekhm1 were expressed in E. coli and purified. Proteins bound to glutathione-Sepharose
beads were incubated with mature osteoclast lysate, and co-purified proteins were visualized by Coomassie blue staining and identified by mass
spectrometry (A) or immunoblotting (B). (C) HA tagged Plekhm1 is co-immunoprecipitated with endogenous LIS1 from mature osteoclast lysate.
Bone marrow macrophages were retrovirally transduced with empty vector (V), full-length (FL), N-terminal half (N), and C-terminal half (C) of mouse
Plekhm1. Mature osteoclasts were lysed and subjected to immunoprecipitation experiments with anti-HA antibody. Immunoprecipitated proteins
were then analyzed by western blotting with anti-LIS1, anti-dynein intermediate chain (DIC) and anti-HA antibodies, respectively. (D) RUN and PH1
domains of Plekhm1 mediate its interaction with LIS1. Bone marrow macrophages were retrovirally transduced with N-terminal half of Plekhm1
without RUN domain (N-DRUN), C-terminal half (C) and C-terminal half depleted in PH1 domain (C-DPH1). Endogenous LIS1 was Immunoprecipitated
by a rabbit polyclonal antibody from mature osteoclasts and the binding of Plekhm1 was detected by monoclonal anti-HA antibody. The multiple low
molecular-weight bands shown in the TCL HA blot for C-terminal Plekhm1 are probably due to the degradation of the protein. MW, molecular mass;
WB, Western blot; IP, immunoprecipitation; TCL, total cell lysate.
doi:10.1371/journal.pone.0027285.g001
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reproduced a similar result (Figure S3). Thus, LIS1 is essential for
both osteoclast formation and function.
LIS1 controls proliferation, survival and differentiation of
osteoclast precursors via modulating M-CSF and RANKL
signaling pathways and NFATc1 expression
The compromised osteoclast formation in LIS1 knockdown
BMMs could be the result of aberrant proliferation, differentiation,
and/or apoptosis of osteoclast precursors and mature cells. To
identify the mechanisms by which LIS1 regulates osteoclastogen-
esis we therefore determined whether LIS1 modulates the
downstream signaling pathways of M-CSF and RANKL, the
two critical cytokines regulating these processes. As shown in
Figure 3A, M-CSF induced prolonged ERK and AKT activation
in control BMMs, which has been shown to be required for
macrophage proliferation and osteoclast survival [29,30]. These
effects were significantly reduced in LIS1 knockdown BMMs.
Silencing of LIS1 also resulted in a sustained JNK activation in
response to RANKL, which has been shown recently to induce
osteoclast apoptosis [31]. On the other hand, RANKL-stimulated
NFkB activation, as demonstrated by the phosphorylation of IkB
was not affected by the LIS1-depletion (Figure 3B). Consistent
with an important role of ERK and AKT pathways in
macrophages, LIS1-deficient BMMs exhibited a decreased
proliferative capacity as measured by BrdU incorporation rate
(Figure 3C). In line with the aberrant JNK activation, LIS1 down-
regulation correlated with an increase in pre-osteoclast apoptosis
under both basal and starvation-induced conditions, as monitored
by caspase-3 activity (Figure 3D) and nuclear staining (Figure S4).
Since NFATc1 is an essential transcription factor for osteoclast
differentiation we went on to test whether LIS1 regulates NFATc1
expression. As shown in Figure 3E, NFATc1 levels were markedly
decreased in LIS1 knockdown mature osteoclasts whereas tubulin
acetylation, which has been shown to modulate microtubules
organization and mature osteoclast spreading, was only slightly
reduced as compared with control cells. Collectively, these data
indicate that LIS1 controls proliferation, survival and differenti-
ation of osteoclast precursors by regulating M-CSF and RANKL
signaling pathways and NFATc1.
LIS1 is essential for the motility of osteoclast precursors
and cathepsin K secretion
LIS1 has been shown to modulate cytoplasmic dynein function
in several cellular processes such as neuronal migration, mitosis
and intracellular membrane trafficking, including lysosome
distribution [32–34]. We next investigated whether LIS1 is
involved in pre-osteoclast migration by using time-lapse video
microscopy on living cells. The 8-hour movements of ten motile
macrophages and pre-osteoclasts in LUC-sh and LIS1-sh
expressing cells were tracked and analyzed with ImageJ MTrackJ
plug-in (National Institutes of Health) (Figure 4A and 4B).
Quantitative analysis of cumulative track lengths revealed a
striking 5-fold decrease in the cell motility of LIS1-depleted
Figure 2. LIS1 is essential for osteoclast formation and function. (A) Knockdown of LIS1 expression by lentivirus mediated shRNAs. Bone
marrow macrophages were transduced with lentiviral vectors expressing a control shRNA (LUC-sh) or LIS1 specific shRNAs (LIS1a-sh and LIS1b-sh),
respectively. Bone marrow macrophages (m), pre-osteoclasts (p) and mature osteoclasts (o) were lysed and analyzed by western blotting. (B) LIS1
down-regulation attenuates multinucleated TRAP
+ osteoclast formation. Scale bar =10 mm. (C) The number of TRAP
+, multinucleated osteoclasts per
well of 48-well plate were counted, n=6. (D) Decreased LIS1 expression blocks osteoclastic bone resorption. Osteoclasts were cultured on cortical
bovine bone slices and resorption pits were labeled with peroxidase-conjugated wheat germ agglutinin. Scale bar =10 mm. (E) The percentage of
resorbed area/bone slice as measured by Ossteomeasure software. n=6. (F) CTx-I level in culture medium was measured by ELISA (E), n=6. WB,
Western blot.=. ** p,0.01 vs LUC-sh by Student’s t-test.
doi:10.1371/journal.pone.0027285.g002
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(Figure 4C and 4D).
To determine whether LIS1 regulates osteoclast lysosomal
trafficking and cathepsin K secretion, two processes that are
essential for osteoclastic bone resorption, LUC-sh and LIS1-sh
transduced BMMs were cultured on glass coverslips or cortical
bovine bone slices with M-CSF and RANKL for 5 days. Mature
osteoclasts were fixed and processed for the labeling with anti-
cathepsin K antibody by immunofluorescence. In contrast to a
dispersed distribution pattern of lysosomes in control osteoclasts
(Figure 5A upper panels), LIS1 knockdown increased the density
of cathepsin K positive lysosomes around the nucleus (Figure 5A
lower panels). The secretion of the enzyme into the resorption
lacuna in resorbing osteoclasts cultured on bone was greatly
reduced as compared to control culture (Figure 5B lower panels).
Taken together, these findings indicate that LIS1 is critical for
osteoclast function through regulating its motility and cathepsin K
secretion.
LIS1 regulates osteoclast microtubule organization
through dynein/dynactin motor complex
LIS1 has been previously shown to regulate microtubule
dynamics and intracellular transportation through its association
with the cytoplasmic dynein/dynactin motor complex in neuronal
Figure 3. LIS1 controls macrophage proliferation, differentiation and survival via modulating M-CSF and RANKL signaling
pathways and NFATc1. (A) Low level of LIS1 inhibits M-CSF induced ERK and AKT activation. LUC-sh and LIS1-sh transduced BMMs were serum and
cytokine starved for 12 hours before stimulated with 50 ng/ml M-CSF for indicated time. ERK and AKT activation were detected by western blots with
anti-phospho-ERK (p-ERK) and anti-phospho-AKT (p-AKT) antibodies. The knockdown efficiency was examined by LIS1 western blot. Western blots for
total ERK (t-ERK), AKT (t-AKT) and DIC serve as loading controls. (B) Depletion of LIS1 results in sustained RANKL induced JNK activation without
changing in NF-kB activation as determined by western blots with anti-phospho-JNK (p-JNK) and anti-phospho-IkB (p- IkB) antibodies. Total JNK (t-
JNK) and IkB (t- IkB) serve as controls. (C) LIS1 knockdown BMMs are less proliferative, as measured by Brdu incorporation ELISA kit. (D) Loss of LIS1
accelerates osteoclast apoptosis. Pre-osteoclasts were either untreated or were serum and cytokine starved for 3 hours. Apoptosis was assessed by a
fluorometric caspase-3 activity assay. (E) LIS1-depletiojn leads to decreased NFATc1 expression in osteoclasts. Bone marrow macrophages (m), pre-
osteoclasts (p), and mature osteoclasts (o) were lysed and the level of NFATc1 and acetylated tubulin (ac-tubulin) was detected by Western blots. b-
tubulin serves as a loading control. * p,0.05, ** p,0.01 vs LUC-sh by Student’s t-test.
doi:10.1371/journal.pone.0027285.g003
The Role of LIS1 in Osteoclasts
PLoS ONE | www.plosone.org 5 November 2011 | Volume 6 | Issue 11 | e27285cells [33,35]. To uncover the mechanisms by which LIS1 controls
osteoclast function we next examined whether LIS1 is involved in
the regulation of dynein/dynactin in osteoclasts. To this end, we
over-expressed V5 tagged mouse LIS1 (LIS1-V5) by retroviral
transduction in BMMs. BMMs were then cultured with M-CSF
and RANKL for 5 days to generate mature osteoclasts. The cells
were lysed and immunoprecipitated with anti-LIS1 polyclonal
antibody. Endogenous p150
glued subunit of dynactin complex and
DIC were co-precipitated with LIS1-V5. Empty vector transduced
cells served as negative control (Figure 6A and 6B). Furthermore,
p150
glued and dynein heavy chain (DHC) were co-localized with
LIS1-V5 in the cytoplasm around the nucleus and peripheral
podosome rings in osteoclasts cultured on glass coverslips
(Figure 6C, 6D, and Figure S5), indicating that LIS1 is a
component of the dynein/dynactin pathway in osteoclasts.
Given that microtubule organization/stabilization is important
for osteoclast activation and function, we then examined the
microtubule distribution in LIS1-silenced osteoclasts. In control
osteoclasts, microtubules were evenly distributed, radiating from
the cytoplasm region around the nucleus to the peripheral
podosome belts in osteoclasts cultured on glass (Figure 7A, left
panel). In osteoclasts resorbing bone, microtubules were localized
at the cortex of basal plasma membrane and over the ruffled
membrane inside the actin-rings (Figure 7B, upper panels). In
contrast, microtubules in osteoclasts lacking LIS1 were morpho-
logically disorganized, often clustering around the nucleus and
failing to extend to the podosome belts in spreading osteoclasts on
glass (Figure 7A, right panel) and the ruffled membrane in bone
resorbing osteoclasts on bone (Figure 7B, lower panels).
Since organellar positioning and microtubule stability are
intimately coupled to the dynein/dynactin motor complex we
next examined the impact of LIS1 down-regulation on dynein/
dynactin complex integrity as assessed by velocity density
sedimentation assays. As shown in Figure 8A, no obvious
differences were observed in the levels of DIC and p150
Glued in
LIS1-depleted osteoclasts. Both proteins migrated to the same
high-density fractions of the gradients in LIS1-depleted osteoclasts
as compared to control cells, indicating that loss of LIS1 did not
Figure 4. LIS1 regulates macrophage and pre-osteoclast motility. BMMs (A) and pre-osteoclasts (B) were cultured in Bioptechs dishes and
the cells were imaged by time-lapse video microscopy. Images were obtained using Scion imaging software at 10 minute intervals for 8 hours. The 8-
hour movements of ten motile osteoclast precursors in each cell group were tracked and analyzed with ImageJ MTrackJ plug-in (A and B). (C and D)
Cumulative length of each track was depicted as microns displaced over 48 images. ** p,0.01 vs LUC-sh by Student’s t-test. Scale bar =100 mm.
doi:10.1371/journal.pone.0027285.g004
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consistent with recent studies [32]. The transportation of
microtubule plus-end capping proteins such as EB1 and CLIP-
170 to the cell periphery and the organization of the Golgi
complex are mediated by LIS1-regulated dynein activity [36–38].
To further determine whether LIS1 regulates dynein function in
osteoclasts we also examined the subcellular localization of
GM130, a marker of Golgi complex, and EB1/CLIP170 in
osteoclasts cultured on coverslips. As shown in Figure 8B, loss of
LIS1 resulted in Golgi apparatus dispersion and fragmentation.
While a fraction of EB1 and CLIP170 was observed to surround
the nucleus, a significant amount of both proteins was found to
localize at the periphery of well-spreading osteoclasts transduced
with LUC-sh (Figure 7C and 8B left panels). Decreased LIS1
expression induced an increased level of EB1 and CLIP170
around the nucleus and there were a reduction of these two
proteins at the cell periphery, suggesting that LIS1 plays an
important role in regulating dynein function in osteoclasts
(Figure 7C right panel and Figure 8B insets). Consistent with this
notion, overexpression of p50 subunit (dynamintin) of dynactin
complex, which has been shown to inhibit dynein/dynactin
complex function, led to a similar change of EB1 distribution to
that of LIS1-knockdown osteoclasts (Figure S6).
Discussion
LIS1 is crucial for neuronal migration, mitosis and intracellular
transportation because of its role in regulating cytoplasmic dynein
Figure 5. LIS1 is essential for cathepsin K secretion in osteoclasts. (A and B) Decreased LIS1 expression inhibits cathepsin K secretion in
osteoclasts. F-actin and Cathepsin K in osteoclasts cultured on glass coverslips (A) and cortical bovine bone slices (B) were labeled by phalloidin and
monoclonal anti-Cathepsin K antibody, respectively. Arrows in (A) demonstrate the aggregation of cathepsin K around the nucleus in LIS-1
knockdown osteoclasts. Arrow heads in (B) indicate the secretion of cathepsin K into the resorption lacuna inside the actin-rings in control
osteoclasts. Scale bars =10 mm.
doi:10.1371/journal.pone.0027285.g005
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the first time, that LIS1 also plays an essential role in osteoclast
formation and function via regulating several distinct but
integrated pathways (Figure 9). First, as in neuronal cells, LIS1
regulates dynein/dynactin function and microtubule organization,
which is critical for osteoclast activation and function. Second,
LIS1 binds to Plekhm1, a newly identified osteoclast lysosome
adaptor protein. Together with dynein/microtubule pathway, the
interaction of LIS1 and Plekhm1 may be required for the special
positioning of lysosomes and the delivery of Cathepsin K to the
ruffled border membrane during osteoclastic bone resorption.
Third, by a hitherto unknown mechanism(s), LIS1 modulates both
the M-CSF and RANKL signaling pathways and hence regulates
the proliferation, differentiation and survival of osteoclast
precursors and mature cells.
Accumulating evidence indicates that microtubule organiza-
tion/stabilization, controlled by microtubule acetylation, plays a
critical role in cytoskeleton reorganization during osteoclast
activation and function [10–13]. In this study, we have provided
compelling data demonstrating that LIS1-regulated dynein
function represents another important pathway essential for
microtubule dynamics in osteoclasts. LIS1 interacted with
dynein/dynactin complex, as revealed by its co-immunoprecipi-
tation and co-localization with dynein and dynactin in mature
polykaryons. Knock-down of LIS1 by shRNA led to a dramatic
alteration of microtubule organization with a marked reduction in
cortical microtubule penetration and a more focused microtubule
network around the nucleus, without a significant change in the
level of microtubule acetylation. Loss of LIS1 did not affect the
integrity of dynein/dynactin complex since similar migration rate
of dynein/dynactin complex was observed in a density-gradient of
LIS1-depleted osteoclast lysates as compared to those of control
cells. However, as in neuronal cells, LIS1 is essential for dynein/
dynactin complex function in osteoclasts because loss of LIS1
resulted in dispersed Golgi apparatus, impaired motility of
osteoclast precursors, and marked changes in the distribution of
Figure 6. LIS1 interacts with dynein/dynactin complex in osteoclasts. (A and C) V5 tagged LIS1 (LIS1-V5) binds to and co-localizes with
endogenous p150
glued subunit of dynactin complex in mature osteoclasts. Bone marrow macrophages were retrovirally transduced with empty
vector (Vec) and LIS1-V5. Mature osteoclasts were lysed and subjected to immunoprecipitation experiments with anti-LIS1 antibody.
Immunoprecipitated proteins were analyzed by Western blotting with anti- p150
glued and anti-V5 antibodies, respectively (A). Osteoclasts cultured
on glass coverslips were fixed and processed for immunofluorescence with anti-V5 and p150 antibodies (C). (B and D) LIS1 binds to DIC and co-
localizes with dynein heavy chain (DHC) in mature osteoclasts. WB, Western blot; IP, immunoprecipitation; TCL, total cell lysate. Scale bar =10 mm.
doi:10.1371/journal.pone.0027285.g006
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CLIP170. Therefore, similar to the situation in neuronal and
other cell types [32,36], LIS1-regulated dynein function mediates
the transportation of microtubule fragments and EB1/CLIP170 to
the microtubule plus-ends at cell cortex which is required for the
capture and stabilization of microtubules at the periphery of
osteoclasts [39].
We have shown that LIS1 binds to the RUN and PH1 domain
of Plekhm1 in osteoclasts. How LIS1-Plekhm1 interaction affects
LIS1-mediated dynein function remains to be further character-
ized. We and others have shown that Plekhm1 is a lysosomal
adaptor protein in osteoclasts and is functionally important for
cathepsin K secretion and bone resorption [15] (Figure S2). Thus,
it is likely that, by binding to LIS1, Plekhm1 may link lysosomes to
microtubules in osteoclasts and mediates their transportation to
the plus-ends of microtubules located at the cortex of the plasma
membrane. LIS1 and its binding proteins, NDE1 and NDEL1,
have been demonstrated to regulate dynein-dependent organelle
Figure 7. LIS1 regulates microtubule organization and EB1 distribution in osteoclasts. (A and B) LIS1 reduction induces condensed
microtubules focused around nucleus. Filamentous actin (F-actin) and microtubules in osteoclasts cultured on glass coverslips (A) and cortical bovine
bone slices (B) were labeled by Alexa-488 conjugated phalloidin and anti-tubulin antibody and were examined by conventional (A) and laser confocal
microscopy (B), respectively. (C) EB1 is clustered around the nucleus and is less transported by dynein to the cell periphery in LIS1 knockdown
osteoclasts (right panel) than in control cells (left panel). Cells were labeled by Hoechst 33258, phalloidin and anti-EB1 monoclonal antibody,
respectively. Scale bars =10 mm.
doi:10.1371/journal.pone.0027285.g007
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on lysosome localization and transportation in osteoclasts is quite
different from that in neuronal and other cells. While loss of LIS1
induces a dispersed pattern of lysosomes in other cells [32,33],
decreased level of LIS1 led to lysosome accumulation around the
nucleus in osteoclasts. The underlying explanation of this distinct
phenotype may lie in the differences between microtubule
organizing center (MTOC) and localization of microtubule
Figure 8. LIS1 modulates cytoplasmic dynein activity in osteoclasts. (A) Loss of LIS1 in osteoclasts does not affect dynein/dynactin complex
integrity as measured by a sucrose gradient sedimentation assay. (B) Decreased LIS1 expression in osteoclasts causes dispersed Golgi apparatus
(arrows in upper panels and inset 1, 3 and 5) and reduced transportation of CLIP170 to the periphery of osteoclasts. Arrows in the middle panels
indicate an increased accumulation of CLIP170 around the nucleus.
doi:10.1371/journal.pone.0027285.g008
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there is a peri-nuclear located MTOC harboring the minus ends of
microtubules. Loss of LIS1 leads to decreased dynein function
which may reduce dynein-mediated microtubule minus-end
oriented transportation of lysosomes [40]. Mammalian osteoclasts,
however, do not have MTOCs during evolution [41]. The
microtubule minus-ends are not nucleus-oriented and the
direction of dynein-mediated transportation remains unclear.
Given that the major cellular function of LIS1 is attributed to its
regulatory role in dynein and microtubules, thus, it is surprised
that LIS1-depleted macrophages exhibited aberrant signaling
pathways downstream of M-CSF and RANKL and decreased
osteoclastogenesis. Although we cannot rule out the possibility that
changes in cell physical properties such as cell shape and motility
induced by abnormal microtubule organization in LIS1 depleted
macrophages may affect cells response to M-CSF and RANKL,
several other mechanisms might contribute to the modulation of
LIS1 in M-CSF and RANKL signaling in osteoclasts. For
example, earlier work has reported that LIS1 interacts with Syk
[42], a non-receptor tyrosine kinase that is downstream of M-CSF,
immunoreceptors with ITAM motif, calcium, and integrin
signaling; and is critical for osteoclastogenesis in vivo and in vitro
[43–46]. The decreased osteoclast formation in Syk
-/- macro-
phages can be rescued by high-dose M-CSF in vitro. Since high-
dose of M-CSF and RANKL could not normalize osteoclast
differentiation in LIS1-depleted cultures (Ye S and Zhao H
unpublished observation) it is unlikely that Syk is a mediator of
LIS1 in M-CSF and RANKL signaling. Both LIS1 and its binding
protein NUDEL have been shown to modulate the activity of
cdc42, a member of small GTPase Rho family, by direct
interaction with cdc42 and its endogenous inactivator cdc42GAP,
respectively [47,48]. We have recently found that cdc42 is
required for bone homeostasis by modulating M-CSF and
RANKL signaling [49]. It is therefore possible that cdc42 plays
a role in mediating LIS1’s action on M-CSF and RANKL
signaling. Another factor which may contribute to the regulation
of LIS1 in M-CSF and RANKL signaling is PAF, an autocrine
lipid messenger which is essential for osteoclast survival and
activity [28]. Whether LIS1 interacts and regulates cdc42 and PAF
in osteoclasts deserves further investigation in the future.
Materials and Methods
Antibodies and reagents
Commercially available antibodies were purchased from the
following resources: rabbit polyclonal anti-Lissencephaly-1, mouse
monoclonal anti-Dynein intermediate chain (74.1) and mouse
monoclonal anti-Cathepsin K antibodies (Millipore); mouse
monoclonal anti-HA antibody (Covance); mouse monoclonal
anti-V5 antibody (Invitrogen); mouse monoclonal anti-GS28,
anti-GM130, anti-p150
Glued and anti-EB1 antibodies (BD Trans-
duction Laboratory); rabbit polyclonal anti-NFATc1 and anti-
Dynein heavy chain antibodies (Santa Cruz); rabbit polyclonal
anti-ERK1/2, mouse monoclonal anti-phospho-ERK1/2
(Thr202/Tyr204), mouse monoclonal anti-Akt (pan) (40D4),
rabbit monoclonal anti-phosphor-Akt (Ser473)(193H12), rabbit
polyclonal anti-JNK, mouse monoclonal anti-phospho-JNK
(Thr183/Tyr185)(G9), rabbit polyclonal anti-IZB-a and mouse
monoclonal anti-phospho-IZB-a (Ser32/36) (5A5) antibodies (Cell
Signaling); mouse monoclonal anti-a-tubulin (DM1A) and anti-
acetylated tubulin (611B1) antibodies (Sigma-Aldrich). Mouse anti-
LIS1 monoclonal antibody was a generous gift from Dr. O Reiner
(The Weizmann Institute of Science, Rehovot, Israel). CLIP170
antibody was kindly provided by Dr. N Galjart (Rotterdam, The
Netherlands). The fluorescein-labeled secondary antibodies used
in immunofluorescence were purchased from Jackson ImmunoR-
esearch Laboratories. Alexa-488 conjugated phalloidin was
obtained from Invitrogen. Hoechst 33342 was from Molecular
Probes (Invitrogen). Hoechst 33258 was from Sigma-Aldrich.
Peroxidase-conjugated wheat germ agglutinin was bought from
Sigma-Aldrich. Protein A/G PLUS-agarose was from Santa Cruz.
Cell culture media and L-Glutamine-penicillin-streptomycin
solution were purchased from Invitrogen and Sigma-Aldrich,
respectively. Fetal bovine serum was purchased from Hyclone.
Bone marrow macrophage and osteoclast cultures
Bone marrow macrophages were prepared as described
previously [50]. Briefly, whole bone marrow was extracted from
tibiae and femora of 8–10 weeks old C57/BL6 mice (purchased
from the Jackson Laboratory and were maintained according to
guidelines of UAMS Institutional Animal Care and Use
Committee, protocol number 3009) and incubated in red blood
cell lysis buffer (150 mM NH4Cl, 10 mM KNCO3, 0.1 mM
EDTA, and pH 7.4) for 5 minutes at room temperature. Bone
marrow cells were collected by centrifugation and were plated in
fresh a-10 medium (a-MEM, 10% heat-inactivated fetal bovine
serum, 100 IU/ml penicillin, 100 mg/ml streptomycin and 2 mM
glutamine) containing 1/10 volume of CMG 14–12 culture
supernatant (which was equivalent to 130 ng/ml of recombinant
M-CSF) in 10 cm petri-dish [51]. Cells were incubated at 37uCi n
5% CO2, 95% air for 4-5 days. Fresh media and M-CSF were
replaced every the other day. Pre-osteoclasts and osteoclasts were
generated after three and five days culture of BMMs with 1/100
vol of CMG 14–12 culture supernatant and 100 ng/ml of
recombinant RANKL, respectively.
Cell proliferation and apoptosis Assays
BMMs were cultured with M-CSF for 3 days. Brdu was then
added to the culture medium and incubated for 6 hours. BrdU
incorporation rate was measured by the Cell Proliferation ELISA
system (Amersham Biosciences) following the manufacturer’s
instructions. For the detection of osteoclast apoptosis, BMMs
Figure 9. A schematic model for LIS1 in osteoclast formation
and function.
doi:10.1371/journal.pone.0027285.g009
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were either untreated or serum and cytokine starved for 3 hours.
Caspase-3 activity was measured as previously reported [52].
Briefly, cells were lysed in 20 mM Tris-HCl (pH 7.5), 150 mM
NaCl, 1 mM EDTA, 10 mM NaF, 1 mM sodium orthovanadate,
5 mg/mL leupeptin, 0.14 U/mL aprotinin, 1 mM phenylmethyl-
sulfonylfluoride, and 1% Triton X-100. Protein concentration was
measured using a Bio-Rad detergent–compatible kit (Bio-Rad).
Lysates (100 mg protein) were incubated with 50 mM DEVD-AFC
in 50 mM HEPES (pH 7.4), 100 mM NaCl, 0.1% CHAPS,
10 mM DTT, 1 mM EDTA, and 10% glycerol. The released
fluorescent AFC was measured in a microplate fluorescence reader
FL500 (Bio Tek Instruments) with excitation/emission wave-
lengths of 340/542 nm.
TRAP and resorption pits stainings and medium CTx
measurement
Bone marrow macrophages were cultured on 48-well tissue
culture plate and bone slices in a-10 medium with 100 ng/ml
RANKL and 1/100 volume of CMG14-12 supernatant for 4–5
days. The fresh medium and cytokines were changed at every the
other day. The cells cultured on plastic dishes were fixed with 4%
paraformaldehyde/PBS and TRAP was stained with a commer-
cial kit (387-A, Sigma). Mature osteoclasts grown on bone slices
were fixed with 4% paraformaldehyde/PBS for 20 minutes. After
washing twice in PBS, the cells were removed from bone slices
with a soft brush. The slices were then incubated with 20 mg/ml
peroxidase-conjugated WGA-lectin (Sigma) for 30–60 min at
room temperature. After washing in PBS twice, 0.52 mg/ml
3,39-diaminobenzidine (Sigma) was added onto the slices for 30
minutes. Samples were mounted with 80% glycerol/PBS and were
observed using a Carl Zeiss microscope equipped with a CCD
camera [53]. The total resorbed area/bone slice was quantified
using Osteomeasure software (Osteomeasure). Medium CTx-1
concentration was determined using CrossLaps for Culture ELISA
kit (Immunodiagnosticsystems) following the manufacture’s in-
struction.
Lentivirus mediated shRNA expression
The RNAi sequence 59-GCAACAGGATCTGAGACTA-39
targeting mRNA of murine LIS1 was selected with RNAi
designing online program from Dharmacon. The RNAi sequences
59-CCATCTCTGAAGCAACAGGAT-39 (LIS1a-sh) and 59-
GCAGATTATCTTCGTTCAAAT-39 (LIS1b-sh) ligated in
LKO.1 lentiviral vector were purchased from Sigma-Aldrich. A
firefly luciferase shRNA was used as a control (59- GCTTACGCT-
GAGTACTTCGA-39). 293-T cells were co-transfected with
LKO.1 gene transfer vector and virus packaging vectors, DH8.2
and VSVG using TransIT-LT1 transfection reagent (Mirus). Virus
supernatants were collected 48 hours after transfection. BMMs
were transduced with virus supernatant for 24 h in the presence of
M-CSF and 20 mg/ml Protamine (Sigma-Aldrich). Cells were then
selected in the presence of 100 ng/ml M-CSF and 6 mg/ml
puromycin (Sigma-Aldrich) for 3 days [54].
Retrovirus mediated BMMs transduction
The HA-tagged full-length of murine plekhm1 was amplified
from an osteoclast cDNA library and the V5 tagged full length of
murine LIS1 (PAFAH1b1) was amplified using pCMV-SPORT6-
PAFAH1b1 (Thermal Open Biosystems) as a template by RT-
PCR with Pfx DNA polymerase (Invitrogen). The cDNAs were
cloned into the pMX-IRES-BSR retrovirus vector. The HA-
tagged N-termimal fragment of plekhm1 (N), N-ter delta RUN
domain, C-terminal fragment of plekhm1 (C) and C-ter delta PH1
domain were amplified by RT-PCR using pMX-BSR-mPlekhm1
as a template and cloned into the pMX-BSR retroviral vector. All
the sequences were verified by DNA sequencing. The recombi-
nant retroviral vectors were transiently transfected into Plat E
packing cells using TransIT-LT1 transfection reagent (Mirus).
Virus was collected 48 hours after transfection. BMMs were
transduced with virus for 24 h in the presence of M-CSF and
20 mg/ml Protamine (Sigma-Aldrich). Cells were then selected in
the presence of M-CSF and 2 mg/ml BSR (Calbiochem) for 3 days
[30].
Time-lapse video microscopy and cell motility assay
For the live cell imaging, 1.4 610
5 of BMMs were plated onto
Bioptechs chamber dishes and cultured with either 100 ng/ml M-
CSF alone (macrophages) or 100 ng/ml M-CSF plus RANKL
(pre-osteoclasts) for 3 days. The cells were imaged under phase
contrast at 10X objective lens with the Bioptechs dish being heated
to 37uC and 5% CO2/Air perfused into the chamber. Mineral oil
was overlayed atop of the medium. Images were obtained using
Scion imaging software at 6 images/hour. The 8-hour movements
of ten motile osteoclast precursors from 48 images were tracked
and analyzed with ImageJ MTrackJ plug-in (National Institutes of
Health). Cumulative Length is depicted as total pixel number
displaced over 48 images (8 hrs).
GST pull-down assay
The cDNA fragments of individual domains of murine Plekhm1
were amplified by RT-PCR using pMX-BSR-mPlekhm1 as a
template and were cloned in-frame into pGEX4T.1 vector. GST
and GST fusion proteins were expressed in Escherichia coli
BL21(DE3)plysS and purified on glutathione-Sepharose 4 Fast
Flow beads (GE Healthcare). For GST pull-downs, 2 mg of GST
and GST fusion proteins in 200 ml of immunoprecipitation (IP)
buffer (20 mM Hepes pH 7.4, 120 mM NaCl, 5%glycerol,
0.5 mM EDTA, 1 mM NaVanidate, 5 mM NaF, 0.2% NP-40)
were incubated with 20 ml of glutathione beads for 1 hour at 4uC.
After washing twice with IP buffer, 2 mg of mature osteoclast
lysate was added to the beads and incubated with rotation for
2 hours at 4uC. The beads were washed 5 times with IP buffer.
The interacting proteins were eluted by boiling with 26SDS gel
loading buffer, and subjected to SDS-PAGE. Resolved proteins
were detected by staining of gels with Coomassie blue and mass
spectrometry or by immunoblotting with anti-LIS1 antibody [55].
Immunoblotting and immunoprecipitation
Cultured cells were washed with ice-cold PBS and lysed in 1x
RIPA buffer (Sigma) containing 1 mM DTT and Complete Mini
EDTA-free protease inhibitor cocktail (Roche). After incubation
on ice for 30 min, the cell lysates were clarified by centrifugation at
14,000 rpm for 15 min at 4uC. 10–30 micrograms of protein were
subjected to 8 or 12% sodium SDS-PAGE gels and transferred
electrophoretically onto PVDF membrane by a semi-dry system
(Bio-Rad). The membrane was blocked in 5% fat-free milk/Tris-
buffered saline-0.1% Tween 20 for 1 h and detected with primary
antibodies at 4uC overnight followed by secondary antibodies
conjugated with horseradish peroxidase (Santa Cruz Biotechnol-
ogy, Santa Cruz, CA). After rinsing 3 times, the membrane was
subjected to Western blot analysis with ECL detection reagent
(Millipore).
For immunoprecipitation, osteoclasts were grown in 15-cm
dishes with M-CSF and RANKL for 4–5 days as described above.
Cells were washed in cold PBS and lysed on ice in H-buffer
(20 mM HEPES, pH 7.4; 1% Triton X-100; 1 mM EDTA;
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cocktail from Roche). Lysates were incubated on ice for 30 min.
The cell lysates were clarified by centrifugation at 14,000 rpm for
15 min. 1–2 mg of total protein were incubated with 2–5 mg
primary antibodies for overnight with rotation at 4uC. Protein A/
G agarose was then added and incubated with rotation for 3 h at
4uC. Immunoprecipitates were washed three times in lysis buffer,
and the beads were boiled in 2x SDS sample buffer for 5 min.
After centrifugation, proteins were separated by 8 or 10% SDS-
PAGE gels.
Immunofluorescence and confocal microscopy
Immunofluorescence was performed as previously described
[56]. In brief, cells grown on glass slides in 24-well plate were fixed
with 4% paraformaldehyde in PBS for 20 minutes, followed by
permeabilization and blocking in PBS/0.2% BSA/0.1% saponin
(PBSBS)for30minutes.Thecellswere thenincubatedwith primary
antibodies in 0.2% BSA/PBS for 2 hours. Primary antibody
binding was visualized using fluorescent dye–conjugated secondary
antibodies (Jackson ImmunoResearch Laboratories Inc.) in 0.2%
BSA/PBS for 45 minutes. F-actin was stained with Alexa488-
phalloidin. Samples were mounted with 80% glycerol/PBS. The
nucleus was labeled with Hoechst 33258. Immunofluorescence-
labeled cells were observed using a Carl Zeiss fluorescence
microscope equipped with a CCD camera and analyzed using a
Zeiss Spectral confocal laser scanning microscope equipped with
Argon-Krypton lasers (LSM510 Zeiss Microsystems, Germany).
Velocity Density Gradient Centrifugation of Dynein-
Dynactin Complexes
Velocity density gradient centrifugation was performed as
previously described in [57] with minor modifications. Briefly,
,10
7 osteoclastic cells were washed with ice-cold PBS, and
scraped with 500 ml of lysis buffer (50 mM HEPES-KOH, pH 7.2,
150 mM NaCl, 1 mM MgCl2) supplemented with protease
inhibitors: 1 mM phenylmethylsufonyl fluoride (PMSF), 1 mg/
ml aprotinin, 1 mg /ml leupeptin and 0.7 mg /ml pepstatin (all
from Sigma), and then homogenized by passing cells through a 25-
gauge syringe (at least 10 strokes). Proteins were then cleared by
centrifugation at 3000 rpm for 15 min at 4uC. 500 ml of the
clarified supernatant was layered on top of 12 ml of 5–20% linear
sucrose density gradient prepared in the lysis buffer. After
centrifugation at 150,000 g for 18 h in a SW40 rotor (Beckman
Coulter), 1 ml fractions were collected, acetone precipitated and
equal amounts analyzed by SDS-PAGE and immunoblotting
using mouse anti-p150
Glued (1:1000), mouse anti-Dynein interme-
diate chain (IC74) (1:1000) and rabbit anti-LIS1 antibodies.
Statistics
Data of 2-group comparisons were analyzed using a 2-tailed
Student’s t test. For all graphs and in the text, data are represented
as mean 6 SD.
Supporting Information
Figure S1 Domain structure and constructs of mouse
Plekhm1.
(TIF)
Figure S2 Plekhm1 is localized at lysosomes and the
ruffled border membrane in osteoclasts and is essential
for Cathepsin K secretion and bone resorption. (A and B)
Plekhm1 is associated with lysosomes in osteoclasts cultured on
glass coverslips. (C) Plekhm1 is localized at the ruffled border
membrane in resorbing-osteoclasts cultured on bovine bone slices.
BMMs were transduced with a retroviral vector expressing the
HA-tagged full length murine Plekhm1. Plekhm1, F-actin, and
LAMP-2 (lysosome associated membrane protein 2) were labeled
with a mouse monoclonal anti-HA antibody, phalloidin, and a rat
monoclonal anti-LAMP-2 antibody, respectively. The cells were
visualized by conventional (A and B) and confocal (C) fluorescent
microscopes. (D) Plekhm1 mRNA and (E) protein expression were
abolished by a lentivirus-mediated shRNA expression. (F) Plekhm1
knockdown osteoclasts form actin-rings normally as compared to
control cells. (G) Cathepsin K secretion, (H) resorption pits
formation and (I) medium CTx-I level were dramatically
decreased in Plekhm1-depleted osteoclast cultures as compared
to controls. Arrows in (G) showed the secreted Cathepsin K in the
resorption lacunae circled by an actin-ring. Scale bars =10 mm.
* in (I), p,0.05 vs LUC-sh by Student’s t-test.
(TIF)
Figure S3 An independent LIS1 shRNA inhibits LIS1
expression and osteoclast formation. (A) Knockdown of
LIS1 expression in macrophages by a second lentivirus-mediated
shRNA. (B) LIS1 down-regulation attenuates multinucleated
TRAP
+ osteoclast formation. Scale bar =10 mm.
(TIF)
Figure S4 LIS1 down-regulation increases pre-osteo-
clast apoptosis. (A) LUC-sh and LIS1-sh transduced macro-
phages were cultured with M-CSF and RANKL for 2 days to
generate pre-osteoclasts. The cells were then either un-treated or
starved for 6 hours before fixation with 4% paraformaldehyde in
PBS for 20 minutes. The nuclei were stained with Hoechst 33258.
The debris of an apoptotic nucleus was shown by arrows. The
scale bar =10 mm. (B) The numbers of apoptotic and total pre-
osteoclasts in each group were counted under conventional
fluorescent microscope. ** p,0.01 vs LUC-sh by Student’s t-test.
(TIF)
Figure S5 LIS1 and p150
Glued are localized at peri-
nuclear cytoplasmic area and the peripheral podosome-
belts. (A) endogenous LIS1, (B) V5 tagged LIS1, and (C)
endogenous p150
Glued in osteoclasts cultured on glass coverslips
were stained with phalloidin and mouse monoclonal anti-LIS1, V5,
and p150
Glued antibodies, respectively. The cells were visualized by
conventional fluorescent microscope. Scale bar =10 mm.
(TIF)
Figure S6 p50 dynamintin overexpression alters EB1
localization in osteoclasts. Bone marrow macrophages were
transduced with either empty vector (pMX) or retroviral vector
expressing p50 dynamintin (pMX-p50) and cultured with M-CSF
and RANKL for 5 days to generate mature osteoclasts on glass
coverslips. The cells were then fixed and labeled with anti-EB1
monoclonal antibody. Scale bar =10 mm.
(TIF)
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